1101579

Nalpropion Pharmaceuticals, Inc. — FEI 3008354913

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)